| Public | NASDAQ:SZYM |
| Raised | |
| Post IPO Valuation |
| Website | solazyme.com |
| Category | CleanTech |
| Employees | |
| Founded | 2003 |
| Description | Algal-derived Biofuel Producer |
| TOTAL | $141M |
| FUNDING TOTAL | $141M |
| Series B, 3/07 Roda Group | $10M |
| Series C, 8/08 Braemar Energy Ventures Lightspeed Venture Partners Harris & Harris Group Roda Group | $45.4M |
| Series D, 6/09 VantagePoint Capital Partners Braemar Energy Ventures Lightspeed Venture Partners Harris & Harris Group Bunge Roda Group | $11.6M |
| Grant, 12/09 | $21.8M |
| Series D, 8/10 Morgan Stanley Chevron Technology Ventures | $52M |
| DEBT TOTAL | $5M |
| Debt, 9/07 Bluecrest Capital Finance | $5M |
Solazyme is a synthetic biology company that specializes in converting algal biomass into biofuels. Solazyme not only creates biofuels for the the transportation industry, but is experimenting with ways to tailor its products for the cosmetic and food industries.